GlassScriptPhysician profile
Kirby L Smith
NPI 1144223298
$4,869.02
in general payments reported to CMS, 2019-2025
51 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,671 · 2020: $828 · 2021: $1,391 · 2022: $880 · 2023: $99.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $474.10 | 2019-2022 | |
| Janssen Biotech, INC. | $406.79 | 2019-2022 | |
| Amgen INC. | $327.21 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $296.23 | 2019-2022 | |
| Glaxosmithkline, LLC. | $262.38 | 2020-2022 | |
| Eisai INC. | $193.84 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $177.66 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $166.83 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $164.91 | 2019-2022 | |
| Daiichi Sankyo INC. | $155.72 | 2019-2022 | |
| Incyte Corporation | $152.92 | 2019-2022 | |
| Astellas Pharma US INC | $147.64 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $145.30 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $143.80 | 2019-2022 | |
| Genzyme Corporation | $126.07 | 2019-2022 |
Show all 51 companies
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirby Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.